157 related articles for article (PubMed ID: 35321452)
1. Multimodal Imaging under Artificial Intelligence Algorithm for the Diagnosis of Liver Cancer and Its Relationship with Expressions of EZH2 and p57.
Zhang Y; Cui J; Wan W; Liu J
Comput Intell Neurosci; 2022; 2022():4081654. PubMed ID: 35321452
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA TALNEC2 plays an oncogenic role in breast cancer by binding to EZH2 to target p57
Qiao E; Chen D; Li Q; Feng W; Yu X; Zhang X; Xia L; Jin J; Yang H
J Cell Biochem; 2019 Mar; 120(3):3978-3988. PubMed ID: 30378143
[TBL] [Abstract][Full Text] [Related]
3. EZH2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vivo.
Guo J; Cai J; Yu L; Tang H; Chen C; Wang Z
Cancer Sci; 2011 Mar; 102(3):530-9. PubMed ID: 21205084
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA HOXD-AS1 aggravates osteosarcoma carcinogenesis through epigenetically inhibiting p57 via EZH2.
Gu W; Zhang E; Song L; Tu L; Wang Z; Tian F; Aikenmu K; Chu G; Zhao J
Biomed Pharmacother; 2018 Oct; 106():890-895. PubMed ID: 30119259
[TBL] [Abstract][Full Text] [Related]
5. Utilization of Ultrasonic Image Characteristics Combined with Endoscopic Detection on the Basis of Artificial Intelligence Algorithm in Diagnosis of Early Upper Gastrointestinal Cancer.
Wang L; Song H; Wang M; Wang H; Ge R; Shen Y; Yu Y
J Healthc Eng; 2021; 2021():2773022. PubMed ID: 34880973
[TBL] [Abstract][Full Text] [Related]
6. LncRNA SNHG17 promotes gastric cancer progression by epigenetically silencing of p15 and p57.
Zhang G; Xu Y; Wang S; Gong Z; Zou C; Zhang H; Ma G; Zhang W; Jiang P
J Cell Physiol; 2019 Apr; 234(4):5163-5174. PubMed ID: 30256413
[TBL] [Abstract][Full Text] [Related]
7. Downregulated LINC00628 aggravates the progression of colorectal cancer via inhibiting p57 level.
Zhang MC; Zhang L; Zhang MQ; Yang GX; Wang FZ; Ding P
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1763-1770. PubMed ID: 32141544
[TBL] [Abstract][Full Text] [Related]
8. Multimodal Imaging of Target Detection Algorithm under Artificial Intelligence in the Diagnosis of Early Breast Cancer.
Jiang M; Lei S; Zhang J; Hou L; Zhang M; Luo Y
J Healthc Eng; 2022; 2022():9322937. PubMed ID: 35047160
[TBL] [Abstract][Full Text] [Related]
9. The KIP/CIP family members p21^{Waf1/Cip1} and p57^{Kip2} as diagnostic markers for breast cancer.
Zohny SF; Baothman OA; El-Shinawi M; Al-Malki AL; Zamzami MA; Choudhry H
Cancer Biomark; 2017; 18(4):413-423. PubMed ID: 28106536
[TBL] [Abstract][Full Text] [Related]
10. CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells.
Yang X; Karuturi RK; Sun F; Aau M; Yu K; Shao R; Miller LD; Tan PB; Yu Q
PLoS One; 2009; 4(4):e5011. PubMed ID: 19340297
[TBL] [Abstract][Full Text] [Related]
11. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S
Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between Expression of Runt-related Transcription Factor 3 and Enhancer of zeste Homolog 2 Proteins and Sensitivity to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer].
Yuan ZL; Wu XL; Qu M; Xue J; Han L; Sun GY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Dec; 43(6):856-864. PubMed ID: 34980322
[TBL] [Abstract][Full Text] [Related]
13. Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma.
Hu T; Guo H; Wang W; Yu S; Han L; Jiang L; Ma J; Yang C; Guo Q; Nan K
Oncol Rep; 2013 Oct; 30(4):1707-14. PubMed ID: 23842948
[TBL] [Abstract][Full Text] [Related]
14. The long non-coding RNA Kcnq1ot1 controls maternal p57 expression in muscle cells by promoting H3K27me3 accumulation to an intragenic MyoD-binding region.
Andresini O; Rossi MN; Matteini F; Petrai S; Santini T; Maione R
Epigenetics Chromatin; 2019 Jan; 12(1):8. PubMed ID: 30651140
[TBL] [Abstract][Full Text] [Related]
15. Expression of p57(kip2) and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma.
Nan KJ; Guo H; Ruan ZP; Jing Z; Liu SX
World J Gastroenterol; 2005 Feb; 11(8):1237-40. PubMed ID: 15754413
[TBL] [Abstract][Full Text] [Related]
16. Expressions of cyclin E, cyclin dependent kinase 2 and p57(KIP2) in human gastric cancer.
Liang B; Wang S; Yang X; Ye Y; Yu Y; Cui Z
Chin Med J (Engl); 2003 Jan; 116(1):20-3. PubMed ID: 12667381
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between expression of p57(kip2), cyclin E protein, PCNA, and clinicopathological factors in human pancreatic cancer].
Yue H; Zhang N; Feng XL; Ma SR; Song FL; Yang M; Tang YH
Ai Zheng; 2003 Jul; 22(7):705-9. PubMed ID: 12866960
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of decorin and p57(KIP2) correlates with poor survival and lymphatic metastasis in lung cancer patients.
Biaoxue R; Xiguang C; Hua L; Hui M; Shuanying Y; Wei Z; Wenli S; Jie D
Int J Biol Markers; 2011; 26(1):9-21. PubMed ID: 21360479
[TBL] [Abstract][Full Text] [Related]
19. p57(kip2) expression is related to carcinogenesis and tumor progression in laryngeal tissues.
Fan GK; Xu F; Yang B; Fujieda S
Acta Otolaryngol; 2006 Mar; 126(3):301-5. PubMed ID: 16618659
[TBL] [Abstract][Full Text] [Related]
20. Expression of p57kip2, Rb protein and PCNA and their relationships with clinicopathology in human pancreatic cancer.
Yue H; Na YL; Feng XL; Ma SR; Song FL; Yang B
World J Gastroenterol; 2003 Feb; 9(2):377-80. PubMed ID: 12532471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
